Targeted therapy for targeted patients: trastuzumab in adjuvant treatment of non-small-cell lung cancer.
Altundag
Kadri
K
Altundag
Ozden
O
Morandi
Paolo
P
Gunduz
Mehmet
M
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung; D006801:Humans; D008175:Lung Neoplasms; D009856:Oncogene Proteins, Viral / Q000378:metabolism; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D012097:Repressor Proteins / Q000378:metabolism; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D009856:Oncogene Proteins, Viral; D018719:Erb-b2 Receptor Tyrosine Kinases; D012097:Repressor Proteins; D000068878:Trastuzumab; C068651:E6 protein, Human papillomavirus type 16